A detailed history of Credit Suisse Ag transactions in Pfizer Inc stock. As of the latest transaction made, Credit Suisse Ag holds 8,614,681 shares of PFE stock, worth $222 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
8,614,681
Previous 8,977,823 4.04%
Holding current value
$222 Million
Previous $258 Million 7.51%
% of portfolio
0.24%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $9.4 Million - $10.8 Million
-363,142 Reduced 4.04%
8,614,681 $239 Million
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $24.7 Million - $32.1 Million
-945,852 Reduced 9.53%
8,977,823 $258 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $11.1 Million - $13 Million
346,059 Added 3.61%
9,923,675 $329 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $8.24 Million - $9.54 Million
228,250 Added 2.44%
9,577,616 $351 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $1.61 Million - $2.09 Million
-40,831 Reduced 0.43%
9,349,366 $381 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $12.2 Million - $16 Million
292,873 Added 3.22%
9,390,197 $481 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $14.6 Million - $17.8 Million
332,560 Added 3.79%
9,097,324 $398 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $8.54 Million - $10.1 Million
183,604 Added 2.14%
8,764,764 $460 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $670,191 - $830,451
14,649 Added 0.17%
8,581,160 $444 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $21.2 Million - $31.5 Million
513,574 Added 6.38%
8,566,511 $506 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $31 Million - $39.8 Million
-788,563 Reduced 8.92%
8,052,937 $346 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $167 Million - $189 Million
-4,655,373 Reduced 34.49%
8,841,500 $346 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $156 Million - $176 Million
-4,663,475 Reduced 25.68%
13,496,873 $489 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $159 Million - $203 Million
4,761,831 Added 35.54%
18,160,348 $668 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $16.3 Million - $19.1 Million
513,876 Added 3.99%
13,398,517 $492 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $69 Million - $83.7 Million
-2,291,362 Reduced 15.1%
12,884,641 $421 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $23 Million - $32.9 Million
852,470 Added 5.95%
15,176,003 $495 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $27.8 Million - $31.5 Million
843,321 Added 6.26%
14,323,533 $561 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $37.5 Million - $48.7 Million
1,155,459 Added 9.38%
13,480,212 $484 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $46.9 Million - $52.6 Million
1,267,499 Added 11.46%
12,324,753 $534 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $94.8 Million - $104 Million
-2,527,930 Reduced 18.61%
11,057,254 $470 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $27 Million - $30.8 Million
-701,781 Reduced 4.91%
13,585,184 $593 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $11.3 Million - $13.7 Million
327,206 Added 2.34%
14,286,965 $630 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $13.3 Million - $14.2 Million
-404,322 Reduced 2.81%
13,959,759 $506 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $41.2 Million - $47.8 Million
-1,291,141 Reduced 8.25%
14,364,081 $510 Million
Q4 2017

Mar 14, 2018

BUY
$33.26 - $35.29 $42.1 Million - $44.7 Million
1,267,009 Added 8.81%
15,655,222 $567 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $1.32 Million - $1.4 Million
-39,812 Reduced 0.28%
14,388,213 $521 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $3.53 Million - $3.88 Million
-113,713 Reduced 0.78%
14,428,025 $515 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,541,738
14,541,738 $488 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.